EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study

Helene Engstrand iD, Maria Bengtson Argren, John-Anker Zwart, Erling Tronvik iD, Bendik Slagsvold Winsvold iD

Cephalalgia · 2025-12 · 45 (12)

DOI: 10.1177/03331024251406103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cephalalgia, online erschienen am 17.12.2025. Verfasst von Helene Engstrand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Migraine Disorders, Quality of Life, Cost of Illness. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The diagnostic criteria for chronic migraine, which are based on the total number of monthly headache days, are the subject of ongoing debate. The present study aimed to investigate and compare the burden of disease and quality of life between high-frequency episodic migraine and chronic migraine, using data from the large population-based PopHEAD study.

Methods

PopHEAD is a population-based cross-sectional study in the Norwegian county of Vestfold and Telemark performed in 2023. Among 28,753 randomly selected adults (aged 18–70 years) invited to complete an electronic questionnaire, 8265 (28.7%) participants responded. The questionnaire was a modified version of the Headache-Attributed Restriction, Disability, Social Handicap and Impaired Participation questionnaire, and migraine was classified using a diagnostic algorithm that has been validated by telephone interview in this population. High-frequency episodic migraine was classified according to newly proposed criteria, and chronic migraine according to International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria. Using linear regression for continuous variables and logistic regression for binary outcomes, we compared the disease burden and quality of life between participants classified with high-frequency episodic migraine and those with chronic migraine. The analysis was conducted in two steps: a primary analysis adjusted for age and sex, as well as a second analysis with an additional adjustment for monthly migraine days.

Results

Of the 8265 responders, 225 had high-frequency episodic migraine and 349 had chronic migraine. Compared to the high-frequency episodic migraine group, the chronic migraine group had more monthly migraine days (17.9 vs. 9.7, p < 0.001) and headache days (20.8 vs. 9.9, p < 0.001). The chronic migraine group also used more acute medication ( p < 0.001). In analyses adjusted for age and sex, participants with chronic migraine reported greater disease burden across almost all measures, including work and social impairment, and had a lower quality of life ( p < 0.01). With additional adjustment for monthly migraine days, no significant differences in disease burden were found between the two groups, except from days missed from household work ( p = 0.03).

Conclusions

The higher disease burden observed in chronic migraine compared to high-frequency episodic migraine was fully explained by the higher number of monthly migraine days in the chronic migraine group. Our findings support previous suggestions to simplify the ICHD-3 criteria for chronic migraine by basing it solely on the number of monthly migraine days.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Migraine DisordersQuality of LifeCost of IllnessHumansAdultMaleFemaleMiddle AgedCross-Sectional StudiesYoung AdultNorwayAgedAdolescentChronic DiseaseSurveys and Questionnaires

Stichwörter der Autor:innen

IHS-classificationchronic migrainehigh-frequency episodic migrainemigraine burdenpopulation-based study

Autor:innen und Institutionen

  • Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
  • Norwegian Centre for Headache Research (NorHead), Department of Neuromedicine and Movement, Norwegian University of Science and Technology, Trondheim, Norway.
  • Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Department of Neurology and Clinical Neurophysiology, St Olav University Hospital, Trondheim, Norway.
  • Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.

ORCID-Profile: Helene Engstrand, Erling Tronvik, Bendik Slagsvold Winsvold

Förderung

  • Norges Forskningsråd

Zitieren

APA

Engstrand, H., Argren, M. B., Zwart, J. A., Tronvik, E., & Winsvold, B. S. (2025). The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study. Cephalalgia, 45(12). https://doi.org/10.1177/03331024251406103

Vancouver

Engstrand H, Argren MB, Zwart JA, Tronvik E, Winsvold BS. The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study. Cephalalgia. 2025;45(12). doi:10.1177/03331024251406103

BibTeX
@article{Engstrand2025,
  author = {Engstrand, Helene and Argren, Maria Bengtson and Zwart, John-Anker and Tronvik, Erling and Winsvold, Bendik Slagsvold},
  title = {The burden of high-frequency episodic migraine and chronic migraine in the population-based PopHEAD study},
  journal = {Cephalalgia},
  year = {2025},
  volume = {45},
  number = {12},
  doi = {10.1177/03331024251406103}
}
Kostenlos starten →